Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Recent publications published by researchers at the MRC WIMM.

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.

Journal article

Tobiasson M. et al, (2024), Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

Journal article

Schreiber K. et al, (2023), The Lancet Rheumatology, 5, e501 - e506

Risk of End-Stage Renal Disease in Patients With Systemic Lupus Erythematosus and Diabetes Mellitus: A Danish Nationwide Cohort Study.

Journal article

Hansen RB. et al, (2023), Arthritis Care Res (Hoboken), 75, 1871 - 1877

Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.

Journal article

Rodriguez-Meira A. et al, (2023), Nat Genet, 55, 1531 - 1541

Epigenetic programming defines haematopoietic stem cell fate restriction.

Journal article

Meng Y. et al, (2023), Nat Cell Biol

Load More